Inhibition of Ferroptosis Alleviates Early Brain Injury After Subarachnoid Hemorrhage In Vitro and In Vivo via Reduction of Lipid Peroxidation
Autor: | Jinju Wang, Yao Liu, Huaizhang Shi, Pei Wu, Ji C. Bihl, Binbing Liu, Yang Tian, Yuchen Li |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Programmed cell death Ferroportin Transferrin receptor Pharmacology GPX4 Neuroprotection Lipid peroxidation 03 medical and health sciences Cellular and Molecular Neuroscience chemistry.chemical_compound 0302 clinical medicine In vivo Medicine cardiovascular diseases biology business.industry Cell Biology General Medicine Glutathione nervous system diseases 030104 developmental biology chemistry biology.protein business 030217 neurology & neurosurgery |
Zdroj: | Cellular and Molecular Neurobiology. 41:263-278 |
ISSN: | 1573-6830 0272-4340 |
DOI: | 10.1007/s10571-020-00850-1 |
Popis: | Subarachnoid hemorrhage (SAH) is a serious cerebrovascular disease with high mortality, and the mean age at morbidity is younger than in other types of stroke. Early brain injury (EBI) plays a key role in the poor prognoses of SAH. In EBI, multiple forms of cell death have been identified and well studied; however, the role of ferroptosis has not been elucidated. Hence, in this study, we developed an in vivo (SAH rat model) and in vitro model (SH-SY5Y oxyhemoglobin injury model) to understand the role of ferroptosis in EBI, then explored the protective mechanism of ferrostatin-1 (Fer-1). Firstly, we found that neurological scores, blood-brain barrier permeability, brain edema deteriorated after SAH in the in vivo model, cell viability was decreased after SAH in both cortex and SH-SY5Y cells. Further, iron content in cortex was increased after SAH, while transferrin receptor 1 and ferroportin (Fpn) were increased in oxyhemoglobin-treated in vitro model. Additionally, glutathione content and glutathione peroxidase 4 activity were reduced in SAH rats, and lipid peroxides were increased in the oxyhemoglobin-treated cells. Finally, administration of Fer-1 upregulated Fpn and decreased the iron content, then improved the lipid peroxidation and EBI. However, Fer-1 had no effect on the apoptosis. Our study indicated that the ferroptosis was involved in EBI of SAH, and the inhibitor Fer-1 provided neuroprotection against EBI by alleviating ferroptosis, the potential protective mechanism might be via suppressing lipid peroxidation. |
Databáze: | OpenAIRE |
Externí odkaz: |